Neurodevelopmental disorder–linked Argonaute mutations permit delayed RISC formation and unusual shortening of miRNAs by 3′→5′ trimming
Proceedings of the National Academy of Sciences · 18.11.2025 · 122 (46)
DOI: 10.1073/pnas.2524644122 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 14.11.2025. Verfasst von Andrew Savidge und 7 weiteren Autor:innen. Beteiligte Einrichtung: Ohio State Biochemistry Program, The Ohio State University, Columbus, OH 43210. Hauptthemen laut MEDLINE: Argonaute Proteins, MicroRNAs, Neurodevelopmental Disorders, Mutation. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIGMS NIH HHS, HHS | NIH | National Institute of General Medical Sciences (NIGMS), NIAID NIH HHS.
Abstract (Originalsprache)
Mutations in Argonaute proteins (AGOs) cause Argonaute syndrome, a neurodevelopmental disorder (NDD), yet the underlying molecular mechanism remains unclear. We determined cryo-electron microscopy (cryo-EM) structures of wild-type (WT) AGO1 and the recurrent, severe causative ΔF180 mutant. AGO1(ΔF180) unexpectedly rearranges the hydrophobic core of the L1 domain to preserve the overall RNA-induced silencing complexes (RISC) architecture and recognize guide RNAs similarly to WT. Functionally, the mutant binds target RNAs like WT but more frequently retains passenger strands, implicating a defect in RISC assembly. Biochemical assays of ΔF180 and L190P mutants revealed normal duplex loading but impaired passenger ejection, exposing guide 3′ ends to 3′→5′ exonucleases and generating abnormally short ~11-nucleotide RNAs. In cells, AGO1(ΔF180), AGO1(G199S), and corresponding AGO2 mutants likewise produced truncated guides. Together, these findings support a model in which defective passenger ejection underlies the pathology of AGO-associated NDDs by rendering microRNAs bound to AGO syndrome mutants susceptible to aberrant 3′ trimming.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Ohio State Biochemistry Program, The Ohio State University, Columbus, OH 43210.
- Center for RNA Biology, The Ohio State University, Columbus, OH 43210.
- Cellular, Molecular and Biochemical Sciences Program, The Ohio State University, Columbus, OH 43210.
- Department of Chemistry and Biochemistry, The Ohio State University, Columbus, OH 43210.
- Molecular, Cellular and Developmental Biology, The Ohio State University, Columbus, OH 43210.
- Department of Biological Chemistry and Pharmacology, The Ohio State University, Columbus, OH 43210.
ORCID-Profile: Andrew Savidge, Huaqun Zhang, Audrey C Kehling, GeunYoung Sim, Zhangfei Shen, Tian-Min Fu, Kotaro Nakanishi
Förderung
- NIGMS NIH HHS
- HHS | NIH | National Institute of General Medical Sciences (NIGMS)
- NIAID NIH HHS
Zitieren
APA
Savidge, A., Zhang, H., Annasaheb Adhav, V., Kehling, A. C., Sim, G., Shen, Z., Fu, T. M., & Nakanishi, K. (2025). Neurodevelopmental disorder–linked Argonaute mutations permit delayed RISC formation and unusual shortening of miRNAs by 3′→5′ trimming. Proceedings of the National Academy of Sciences, 122(46). https://doi.org/10.1073/pnas.2524644122
Vancouver
Savidge A, Zhang H, Annasaheb Adhav V, Kehling AC, Sim G, Shen Z, et al. Neurodevelopmental disorder–linked Argonaute mutations permit delayed RISC formation and unusual shortening of miRNAs by 3′→5′ trimming. Proceedings of the National Academy of Sciences. 2025;122(46). doi:10.1073/pnas.2524644122
BibTeX
@article{Savidge2025,
author = {Savidge, Andrew and Zhang, Huaqun and Annasaheb Adhav, Vishal and Kehling, Audrey C and Sim, GeunYoung and Shen, Zhangfei and Fu, Tian-Min and Nakanishi, Kotaro},
title = {Neurodevelopmental disorder–linked Argonaute mutations permit delayed RISC formation and unusual shortening of miRNAs by 3′→5′ trimming},
journal = {Proceedings of the National Academy of Sciences},
year = {2025},
volume = {122},
number = {46},
doi = {10.1073/pnas.2524644122}
}
EUVIMED